Intraoperative drug delivery to hindbrain tumours via an injectable hydrogel is well tolerated and confers survival benefit against atypical teratoid/rhabdoid xenografts

Cara Moloney; Phoebe McCrorie; Amr ElSherbeny; Harry Porter; Chiara Bastiancich; Hasan Slika; Aanya Shahani; Emre Derin; Esteban Velarde; Jackson Miller; John Theodore; Khushi Varshney; F. N. U. Ruchika; Hulya Bayraktutan; Umut Can Oz; Pam Collier; Simon M. L. Paine; Paul Handley; Keith Dredge; Grzegorz Wicher; Richard G. Grundy; Henry Brem; Karin Forsberg-Nilsson; Stuart J. Smith; Betty Tyler; Cameron Alexander; Ruman Rahman